RxDoctor Payments Data

Amy Sadler, MD

Family Medicine · Columbia City, INNPI 1033367123

Payments from drug & device makers

$1,768in general payments, 2019–2025

Across 109 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$385
  • Abbott$245
  • AstraZeneca$216
  • Novo Nordisk$138
  • Astellas Pharma US Inc$112
  • Lilly USA, LLC$96
  • plus $576 from 16 others

What the payments were for

  • Food & beverage$1,768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,768 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$60,871
Medicare patients
179
Services billed
4,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$92,932
JardianceEmpagliflozin84$90,498
JanuviaSitagliptin Phosphate59$80,684
EliquisApixaban61$54,725
TrulicityDulaglutide34$45,315
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$42,766
XareltoRivaroxaban30$37,026
Breo ElliptaFluticasone/Vilanterol38$25,836
MounjaroTirzepatide26$25,697
MyrbetriqMirabegron34$24,420
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr31$22,316
LinzessLinaclotide19$19,050
Tresiba Flextouch U-100Insulin Degludec13$14,811
Tresiba Flextouch U-200Insulin Degludec12$14,024
TradjentaLinagliptin18$11,726

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$47$102,224102 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta$87$96,108132 claims
Novo NordiskOzempic$138$92,93258 claims
Lilly USA, LLCTrulicity, Mounjaro$96$71,01260 claims
PfizerEliquis$85$54,72561 claims
Astellas Pharma US IncMyrbetriq$112$24,42034 claims
AbbVieLinzess, Synthroid$385$21,48261 claims
AstraZenecaSymbicort$216$2,63811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Columbia City

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →